GlaxoSmithKline (GSK) has reinforced its commitment to Pakistan by announcing it will increase investment in consumer healthcare brands over the next five years.

It will do so via the introduction of new brands in its Wellness, Oral Health and Nutrition portfolios; said John Sayers, Presi-dent of GSK Consumer Health for Asia, Pacific, Latin America, Africa and Middle East (APLAM) at a press conference held at local hotel.
Sayers was accompanied by members of his Leadership Team including Ambati Venu, Vice President and General Manager for the Middle East and Sohail Matin, General Manager for Pakistan.

Sayers spoke at length on GSK’s commitment to Pakistan as an emerging market on which there will be extensive focus in the coming years.
He explained that GSK had identified emerging markets such as Pakistan as future growth drivers for the company.
“Pakistan offers a diverse population pool that has significant growth potential and is strongly registering on our consumer healthcare investment radar,” stated Ambati Venu.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Tags:

Related Corporate Updates


whatsapp--v1